NOS2 and amyotrophic lateral sclerosis: This upregulation could be meaningful to ALS pathogenesis because genetic deletion of NOS2 (64) and systemic pharmacological inhibition of NOS2 (86) extend the lifespan of non-conditional hSOD1-G93A tg mice.